The effect of Lavender essential oil in treatment of headache.

A clinical trial for comparing the effect of aromatherapy with Lavender essential oil with Acetaminophen tablet 325 mg in treatment of headache in patient receiving Nitroglycerine infusion.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015033121569N1

Enrollment

135

Registered

2015-07-15

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

headache. Vascular headache, not elsewhere classified

Interventions

Intervention 1: 3 drops of Lavender Essential Oil is inhaled for 30 minutes as soon as headache beginning. Intervention 2: One 325 mg Acetaminophen tablet is used orally as soon as headache beginning.

Treatment - Other

Treatment - Drugs

Placebo

3 drops of Lavender Essential Oil is inhaled for 30 minutes as soon as headache beginning.

One 325 mg Acetaminophen tablet is used orally as soon as headache beginning.

3 drops of liquid paraffin is inhaled for 30 minutes as soon as headache beginning.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18 to 65; Written consent to participate in research; The ability to ?speak Persian; No record of Allergic Rhinitis; No record of respiratory problems; Not using analgesic drugs before admission; Having no headache; No diagnosed psychiatric disorder; Being aware of time, place and subject; No record of olfactory ?dysfunction; No addiction; Having a maximum score of 31 based on Spielberger State-anxiety questionnaires score. Exclusion criteria: Patient unwillingness to participate in the research; Use analgesics drugs; Sensitivity to lavender ?aroma.?

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Headache Severity. Timepoint: Before and 15,30 and 60 minutes after intervention. Method of measurement: Visual Analog Scale.;Headache Quality. Timepoint: Before and 15,30 and 60 minutes after intervention. Method of measurement: Modify Short Form McGill Pain Questionnaire.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Eshghi

Mashhad University of Medical Sciences

eshghie901@mums.ac.ir; eh.san36@yahoo.com; eh.san36@mihanmail.ir+98 51 3525 1751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026